These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 19713977)
1. Intravitreal bevacizumab for choroidal neovascularization associated with a retinochoroidal coloboma. Rajendran A; Gupta SR; Brahadeesh S; Ramasamy K Eye (Lond); 2010 May; 24(5):933-4. PubMed ID: 19713977 [No Abstract] [Full Text] [Related]
2. Choroidal neovascularization associated with coloboma of the choroid: a series of three cases. Bhende M; Suganeswari G; Gopal L; Bhende PS; Gopal L; Rao C Indian J Ophthalmol; 2011; 59(2):148-51. PubMed ID: 21350286 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab in choroidal neovascularization associated with congenital choroidal and optic nerve coloboma in children: long-term improvement in visual acuity. Naithani P; Vashisht N; Mandal S; Sankaran P; Garg S J AAPOS; 2010 Jun; 14(3):288-90. PubMed ID: 20603066 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to traumatic choroidal rupture. Chanana B; Azad RV; Kumar N Eye (Lond); 2009 Nov; 23(11):2125-6. PubMed ID: 19169235 [No Abstract] [Full Text] [Related]
5. [Intravitreal Bevacizumab injections in a child with choroidal neovascularization--case report]. Krzyzanowska-Berkowska P; Barć A; Oficjalska J Klin Oczna; 2011; 113(1-3):60-3. PubMed ID: 21853954 [TBL] [Abstract][Full Text] [Related]
6. Antivascular Endothelial Growth Factor Monotherapy for Choroidal Neovascularization Associated With Retinochoroidal Coloboma: Case Series. Bondalapati S; Jalali S; Chhablani J Asia Pac J Ophthalmol (Phila); 2016; 5(5):344-8. PubMed ID: 26918902 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration. Jonas JB; Tao Y; Rensch F Acta Ophthalmol; 2011 Feb; 89(1):e105-7. PubMed ID: 20064119 [No Abstract] [Full Text] [Related]
8. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Arevalo JF; Adan A; Berrocal MH; Espinoza JV; Maia M; Wu L; Roca JA; Quiroz-Mercado H; Ruiz-Moreno JM; Serrano MA; Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239 [TBL] [Abstract][Full Text] [Related]
9. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization. Ruiz-Moreno JM; Montero JA; Arias L; Araiz J; Gomez-Ulla F; Silva R; Piñero DP Retina; 2010; 30(10):1609-15. PubMed ID: 20856171 [TBL] [Abstract][Full Text] [Related]
10. Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy. Pai SA; Shetty R Acta Ophthalmol; 2009 Nov; 87(7):806-7. PubMed ID: 18721250 [No Abstract] [Full Text] [Related]
11. Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis. Guthoff R; Goebel W Acta Ophthalmol; 2009 Sep; 87(6):688-90. PubMed ID: 18631326 [No Abstract] [Full Text] [Related]